"10.1371_journal.pone.0057800","plos one","2013-02-27T00:00:00Z","Stefanos Leptidis; Hamid el Azzouzi; Sjoukje I Lok; Roel de Weger; Serv Olieslagers; Natasja Kisters; Gustavo J Silva; Stephane Heymans; Edwin Cuppen; Eugene Berezikov; Leon J De Windt; Paula da Costa Martins","Department of Cardiology, CARIM School for Cardiovascular Diseases, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands; Hubrecht Institute, Royal Netherlands Academy of Sciences, Utrecht, The Netherlands","Conceived and designed the experiments: SL HeA SIL SO EC EB LJDW PdCM. Performed the experiments: SL HeA SO NK GJS EC. Analyzed the data: SL HeA RdW EB LJDW PdCM. Contributed reagents/materials/analysis tools: RdW EC EB LJDW PdCM SH. Wrote the paper: SL HeA LJDW PdCM.","The authors have read the journals policy and have the following conflicts: E.C. and E.B. are co-founders and scientific advisory board members of InteRNA Genomics BV. P.D.C.M. and L.D.W. filed and licensed a cardiovascular miRNA patent titled Means and methods for counteracting, delaying and/or preventing heart disease. All other authors report no conflict of interest. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","02","Stefanos Leptidis","SL",12,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
